Immediate Impact

1 by Nobel laureates 5 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
2024 Standout
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
1 intermediate paper

Works of Richard Hernandez being referenced

GEN-009, a neoantigen vaccine containing ATLAS selected neoantigens, to generate broad sustained immunity against immunogenic tumor mutations and avoid inhibitory peptides.
2020

Author Peers

Author Last Decade Papers Cites
Richard Hernandez 116 215 24 269 13 521
Yongbiao Guan 178 250 41 252 21 628
Fortuna Haviv 71 322 31 233 23 609
Gary D. Probst 28 226 46 187 17 541
Eun Jung Ko 85 256 6 203 24 611
Anne M. Strimpler 156 281 61 156 18 582
Bidhan A. Shinkre 36 257 21 276 17 607
Jeremy A. Smith 113 366 45 123 16 633
John Tulinsky 56 303 10 158 13 489
Hanna Hailu 99 431 57 207 9 599
Wenjin Yang 171 290 12 152 11 511

All Works

Loading papers...

Rankless by CCL
2026